A clinical trial of MK-1045 and rituximab in people with follicular lymphoma (MK-1045-007)

Trial Identifier: 1045-007
Sponsor: Merck
Start Date: June 2026
Primary Completion Date: July 2032
Study Completion Date: July 2035
Condition: Lymphoma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Israel, N/A Jerusalem, N/A, Israel, 9112001
Israel, N/A Ramat Gan, N/A, Israel, 5265601
Spain, Barcelona Barcelona, Spain, 08035
Spain, Madrid Madrid, Spain, 28007
Spain, Malaga Málaga, Malaga, Spain, 29010
Taiwan, Taoyuan Taoyuan, Taiwan, 333
Turkey, Ankara Ankara, Turkey, 06230
United States, TN Nashville, TN, United States, 37203